Search

Search Constraints

You searched for: Author/Creator Chang, Kuo‐Chin

Search Results

1. A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation. Issue 6 (June 2017)

2. Clinical and novel application of FibroScan, FIB‐4 and aspartate aminotransferase‐to‐platelet ratio index in liver fibrosis evaluation in patients with hepatocellular carcinoma and their roles in oesophageal variceal prediction. Issue 4 (19th January 2021)

3. Comparing the efficacy and clinical outcome of telbivudine and entecavir naïve patients with hepatitis B virus‐related compensated cirrhosis. Issue 3 (March 2014)

4. Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV‐ and HCV‐endemic area of Southern Taiwan. Issue 8 (8th February 2013)

5. Did AFP‐L3 save ultrasonography in community screening?. Issue 10 (11th June 2018)

6. Evolution of renal function under direct‐acting antivirals treatment for chronic hepatitis C: A real‐world experience. Issue 12 (7th October 2019)

7. Five‐year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment‐naïve patients with chronic hepatitis B‐related compensated cirrhosis in Taiwan. Issue 11 (27th October 2020)

9. Liver stiffness measurement at complete virological response in hepatoma prediction for HBV‐related cirrhosis patient with potent antiviral agent. Issue 11 (20th August 2019)

10. Role of hepatitis B surface antigen in hepatitis B virus relapse after entecavir or tenofovir prophylaxis in patients undergoing cancer chemotherapy. Issue 10 (17th April 2018)